CrystalGenomics Inc banner
C

CrystalGenomics Inc
KOSDAQ:083790

Watchlist Manager
CrystalGenomics Inc
KOSDAQ:083790
Watchlist
Price: 1 407 KRW 10.44% Market Closed
Market Cap: ₩108.2B

CrystalGenomics Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

CrystalGenomics Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
C
CrystalGenomics Inc
KOSDAQ:083790
Other Items
₩22B
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
12%
Celltrion Inc
KRX:068270
Other Items
-₩14.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OliX Pharmaceuticals Inc
KOSDAQ:226950
Other Items
-₩97.3B
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
Other Items
₩23.5B
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Items
-₩202.5B
CAGR 3-Years
N/A
CAGR 5-Years
-48%
CAGR 10-Years
-26%
A
ABL Bio Inc
KOSDAQ:298380
Other Items
₩3.1B
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CrystalGenomics Inc
Glance View

Market Cap
108.2B KRW
Industry
Biotechnology

CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2006-01-06. The firm operates its business through four segments. The Drug Substance Manufacturing segment manufactures and sells drug substances such as anti-inflammatory analgesics, antispasmodics, and asthma treatments. The Finished Drug Manufacturing segment produces and supplies finished drugs such as cephalosporin antibiotics. The Pharmaceutical Research and Development segment is engaged in the provision of clinical trial analysis and technical services, and sales of new drugs. The company also engages in real estate rental business. The Other segment is engaged in the manufacture and sale of hot pats and other household goods.

Intrinsic Value
Not Available
C

See Also

What is CrystalGenomics Inc's Other Items?
Other Items
22B KRW

Based on the financial report for Sep 30, 2025, CrystalGenomics Inc's Other Items amounts to 22B KRW.

What is CrystalGenomics Inc's Other Items growth rate?
Other Items CAGR 10Y
12%

Over the last year, the Other Items growth was -49%. The average annual Other Items growth rates for CrystalGenomics Inc have been 51% over the past three years , and 12% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett